Evaluation of Antibody Response to Heterologous Prime–Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study

Evaluation of Antibody Response to Heterologous Prime–Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study

In several countries, thrombotic events after vaccination with ChAdOx1 nCoV-19 have led to heterologous messenger RNA (mRNA) boosting. We tested the antibody response to SARS-CoV-2 spike protein four weeks after heterologous priming with the ChAdOx1 (ChAd) vector vaccine followed by boosting with BN...

Full description

Bibliographic Details
Main Authors: Davide Firinu, Andrea Perra, Marcello Campagna, Roberto Littera, Federico Meloni, Francesca Sedda, Maria Conti, Giulia Costanzo, Monica Erbi, Gianmario Usai, Carlotta Locci, Mauro Giovanni Carta, Riccardo Cappai, Germano Orrù, Stefano Del Giacco, Ferdinando Coghe, Luchino Chessa
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Vaccines
Subjects:
COVID-19
vaccination
immunogenicity
heterologous
ChAdOx1
BNT162b2
Online Access:https://www.mdpi.com/2076-393X/9/12/1478

Internet

https://www.mdpi.com/2076-393X/9/12/1478

Similar Items